From survival to survivorship: late side effects become an issue in high-grade glioma

Expert Rev Neurother. 2010 Oct;10(10):1493-5. doi: 10.1586/ern.10.123.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / mortality
  • Central Nervous System Diseases / drug therapy
  • Central Nervous System Diseases / mortality
  • Disease Progression
  • Glioma / drug therapy*
  • Glioma / mortality
  • Humans
  • Molecular Targeted Therapy / adverse effects*
  • Survival Rate
  • Time Factors